The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Insulin Signaling in Health and Disease
Abstract
The signaling pathways used by insulin have been identified [M. White, Insulin Signaling Pathway, Sci. STKE (Connections Map, as seen November 2003), http://stke.sciencemag.org/cgi/cm/cmp_12069]. Now our challenge is to understand how the failure of these signals is associated with obesity and the progressive failure of pancreatic beta cells that leads to diabetes. Whether better management of chronic inflammation can improve insulin action is an important area of investigation. Drugs that stimulate IRS2 (insulin receptor substrate protein 2) synthesis or signaling might be a good starting point. This knowledge will lead to rational strategies that prevent or cure diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Physiologically, IRS-1 is phosphorylated at tyrosine residues by the tyrosine kinase activity of the IR, which activates downstream signaling in the insulin pathway (Araki et al., 1994; White, 2003).”
From The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease (2011) · cites this paper as White, 2003
Citations
Cites
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects
Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M., et al. (2003) · Nature · doi:10.1038/nature01705 · Cited by 3,176
Ogg, S., Paradis, S., Gottlieb, S., Patterson, G. I., Lee, L., Tissenbaum, H. A., & Ruvkun, G. (1997) · Nature · doi:10.1038/40194 · Cited by 1,935
Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein
Sun, X. J., Rothenberg, P., Kahn, C. R., Backer, J. M., Araki, E., Wilden, P. A., Cahill, D. A., Goldstein, B. J., & White, M. F. (1991) · Nature · doi:10.1038/352073a0 · Cited by 1,574
Self-citationInsulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., et al. (2003) · Nature · doi:10.1038/nature01667 · Cited by 1,487
Aguirre, V., Werner, E. D., Giraud, J., Lee, Y. H., Shoelson, S. E., & White, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m101521200 · Cited by 1,010
Self-citationFrasca, F., Pandini, G., Scalia, P., Sciacca, L., Mineo, R., Costantino, A., Goldfine, I. D., Belfiore, A., & Vigneri, R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3278 · Cited by 897
Savkur, R. S., Philips, A. V., & Cooper, T. A. (2001) · Nature Genetics · doi:10.1038/ng704 · Cited by 795
Flagged first, then by citations
Research works printed but not linked: 3
- M. White Insulin Signaling Pathway Sci. STKE (Connections Map as seen November 2003) http://stke.sciencemag.org/cgi/cm/cmp_12069.
- G. S. Hotamisligil, B. M. Spiegelman, Science259, 87 (1999).
- D. L. Krebs, D. J. Hilton, Sci. STKE.2003, E6 (2003).
Cited by
Sorted by citations
Items 101–200 of 732
Insulin resistance in Alzheimer's disease
Dineley, K. T., Jahrling, J. B., & Denner, L. A. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.09.001 · Cited by 125
“…D P R O O F synthesis through the target of rapamycin complexes, including mTOR (mammalian target of rapamycin), to control AMPK, energymetabolism, mitochondrial function, synaptic plasticity and memory (Cheng et al., 2010; Kleinridders et al., 2014; Stoica et al., 2011; White, 2003).”
BackgroundMethodInfluentialHuang, D.-W., Chang, W.-C., Wu, J. S., Shih, R.-W., & Shen, S. (2015) · Nutrition Research · doi:10.1016/j.nutres.2015.10.001 · Cited by 121
“[29] White MF.”
BackgroundInfluentialUrayama, A., & Banks, W. A. (2008) · Endocrinology · doi:10.1210/en.2008-0008 · Cited by 121
Giani, J. F., Gironacci, M. M., Muñoz, M. C., Peña, C., Turyn, D., & Dominici, F. P. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01395.2006 · Cited by 119
Insulin receptor substrate signaling suppresses neonatal autophagy in the heart
Riehle, C., Wende, A. R., Sena, S., Pires, K. M., Pereira, R. O., Zhu, Y., Bugger, H., Frank, D., Bevins, J., Chen, D., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci71171 · Cited by 114
“Studies in transgenic mice revealed differential roles for IRS1 and IRS2 signaling in nutrient homeostasis and somatic growth (25).”
Dietary Flavonoids in the Prevention of T2D: An Overview
Alkhalidy, H., Wang, Y., & Liu, D. (2018) · Nutrients · doi:10.3390/nu10040438 · Cited by 123
Hosooka, T., Noguchi, T., Kotani, K., Nakamura, T., Sakaue, H., Inoue, H., Ogawa, W., Tobimatsu, K., Takazawa, K., Sakai, M., et al. (2008) · Nature Medicine · doi:10.1038/nm1706 · Cited by 114
“dtd" [ ]> Insulin receptor substrate (IRS)-1 and IRS-2 have dominant roles in the action of insuli”
Jk, L., & Weng, M.-S. (2006) · Springer eBooks · doi:10.1007/978-0-387-28822-2_8 · Cited by 119
Qi, Y., Chen, L., Zhang, L., Liu, W.-B., Chen, X.-Y., & Yang, X. (2012) · Experimental Eye Research · doi:10.1016/j.exer.2012.11.011 · Cited by 113
Associations among IRS1, IRS2, IGF1, and IGFBP3 Genetic Polymorphisms and Colorectal Cancer
Slattery, M. L., Samowitz, W. S., Curtin, K. P., Ma, K.-N., Hoffman, M. D., Caan, B. J., & Neuhausen, S. L. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.1206.13.7 · Cited by 112
“Cancer Epidemiol Biomarkers Prev 2004;13(7).”
BackgroundInfluentialEndoplasmic Reticulum Stress and the Unfolded Protein Response
Kapoor, A., & Sanyal, A. J. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.07.004 · Cited by 113
Glucose metabolism and AD: evidence for a potential diabetes type 3
González, A., Calfío, C., Churruca, M., & Maccioni, R. B. (2022) · Alzheimer's Research & Therapy · doi:10.1186/s13195-022-00996-8 · Cited by 112
“It is very possible to go from mild cognitive impairment to AD if glucose metabolism is altered [58, 77].”
BackgroundInsulin receptor substrate signaling controls cardiac energy metabolism and heart failure
Guo, C., & Guo, S. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0679 · Cited by 107
“…directly phosphorylates tyrosine residues on several substrates including IRS-1,-2,-3,-4, Shc, Grb-2-assocated protein (Gab1), Dock1, Cbl and APS adaptor proteins, subsequently providing specific docking sites for other signaling proteins in activating downstream protein kinases (White 2003).”
BackgroundInfluentialMitotic Checkpoint Regulators Control Insulin Signaling and Metabolic Homeostasis
Choi, E., Zhang, X., Xing, C., & Yu, H. (2016) · Cell · doi:10.1016/j.cell.2016.05.074 · Cited by 107
“The main framework of insulin signaling has been established for decades (White, 2003).”
Dmitriev, L. F., & Титов, В. Н. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.09.004 · Cited by 105
Luvizotto, R. D. A. M., do Nascimento, A. F., Imaizumi, E., Pierine, D. T., Conde, S. J., Corrêa, C. R., Yeum, K., & Ferreira, A. L. A. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114513001256 · Cited by 107
Targeting the Akt Kinase to Modulate Survival, Invasiveness and Drug Resistance of Cancer Cells
Cassinelli, G., Zuco, V., Gatti, L., Lanzi, C., Zaffaroni, N., Colombo, D., & Perego, P. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990106 · Cited by 104
Romero-Díaz, C., Duarte‐Montero, D., Gutiérrez-Romero, S. A., & Mendivil, C. O. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00964-1 · Cited by 107
Alzheimer’s Disease: Mechanism and Approach to Cell Therapy
Amemori, T., Jendelová, P., Růžička, J., Urdzíková, L. M., & Syková, E. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125961 · Cited by 110
“There are four members: IRS-1, IRS-2, IRS-3 and IRS-4 [192].”
BackgroundDierssen, M., Fructuoso, M., de Lagrán, M. M., Marzia Perluigi, A., & Barone, E. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00670 · Cited by 106
“…as scaffold protein driving the activation of the two main arms of the insulin signaling pathway: (1) the phosphatidylinositol 3-kinase/3phosphoinositide-dependent protein kinase 1/protein kinase B (PI3K/PDK1/Akt) and (2) the mitogen-activated protein kinase (MAPK) pathways (White, 2003; Figure 2).”
BackgroundRen, H., Accili, D., & Duan, C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909570107 · Cited by 106
“The IGF1R uses two major intracellular signaling pathways, namely the phosphatidylinositol 3-kinase (PI3K)–Akt cascade and the Raf-MEK-mitogen–activated protein kinase (MAPK)–extracellular signal-regulated kinase (Erk) cascade (7).”
BackgroundMontagut, G., Onnockx, S., Vaqué, M., Bladé, C., Blay, M., Fernández-Larrea, J., Pujadas, G., Salvadó, M. J., Arola, L., Pirson, I., et al. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.02.003 · Cited by 101
“This initiates the two major signaling cascades: (1) the phosphatidylinositol 3-kinase (PI3K) pathway that includes activation of Akt leading to activation of glycogen synthase and the other enzymes/proteins necessary for the acute metabolic effects of insulin and (2) the mitogen-activated protein kinase (MAPK) pathwa…”
BackgroundNew Insights into Fatty Acid Modulation of Pancreatic β‐Cell Function
Haber, E. P., Procópio, J., Carvalho, C. R. D. O., Carpinelli, Â. R., Newsholme, P., & Curi, R. (2006) · International review of cytology · doi:10.1016/s0074-7696(06)48001-3 · Cited by 98
Hypoxia in Obesity and Diabetes: Potential Therapeutic Effects of Hyperoxia and Nitrate
Norouzirad, R., González‐Muniesa, P., & Ghasemi, A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/5350267 · Cited by 99
“The insulin signaling pathways have been previously reported in detail by several authors [51, 52].”
Hypercatabolic Syndrome: Molecular Basis and Effects of Nutritional Supplements with Amino Acids
Pasini, E., Aquilani, R., Dioguardi, F. S., D’Antona, G., Gheorghiade, M., & Taegtmeyer, H. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.02.074 · Cited by 94
Hou, G., Zhang, S., Zhang, X., Wang, P., Hao, X., & Zhang, J. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2404-y · Cited by 94
“A study reported that the interaction between insulin and its receptor could active the PI3K and Ras–MAPK pathways, which promotes cell proliferation and inhibits cell apoptosis [30].”
BackgroundAkt phosphorylates insulin receptor substrate to limit PI3K-mediated PIP3 synthesis
Kearney, A. L., Norris, D. M., Ghomlaghi, M., Wong, M. K. L., Humphrey, S. J., Carroll, L., Yang, G., Cooke, K. C., Yang, P., Geddes, T. A., et al. (2021) · eLife · doi:10.7554/elife.66942 · Cited by 94
“IRS1 and IRS2 are the primary adaptor proteins responsible for recruiting PI3K to the PM following insulin stimulation (White, 2003).”
BackgroundBáez, A. M., Ayala, G., Pedroza-Saavedra, A., González-Sánchez, H. M., & Chihu-Amparán, L. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46010041 · Cited by 109
“In mice, Ser307 (equivalent to human IRS-1 Ser312) has additionally been identified as a phosphorylation site on IRS-1, and it has been associated with different signaling cascades, including the mTOR pathway [4,27].”
BackgroundSoczynska, J. K., Kennedy, S. H., Goldstein, B. I., Lachowski, A. M., Woldeyohannes, H. O., & McIntyre, R. S. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2009.03.004 · Cited by 96
Minireview: Structural and Functional Evolution of the Thyrotropin Receptor
Farid, N. R., & Szkudlinski, M. W. (2004) · Endocrinology · doi:10.1210/en.2004-0437 · Cited by 93
Zhong, L., Georgia, S., Tschen, S.-I., Nakayama, K., Nakayama, K., & Bhushan, A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32198 · Cited by 92
The Roles of Vitamin A in the Regulation of Carbohydrate, Lipid, and Protein Metabolism
Chen, W., & Chen, G. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3020453 · Cited by 96
“concurrently with profound alterations in glucose and lipid metabolism [9,15,16].”
BackgroundZheng, M., & Wang, P. (2021) · 3 Biotech · doi:10.1007/s13205-021-02738-3 · Cited by 110
“Indeed, phosphorylation of IRS-1 at tyrosine residues contributes to signaling functions, whereas phosphorylation at serine residues inhibits the dissociation of IRS-1 from the insulin receptor and diminishes tyrosine phosphorylation, which results in insulin signaling dysregulation (White 2003).”
BackgroundZhang, Q., Pan, Y., Wang, R., Kang, L.-L., Xue, Q., Wang, X., & Kong, L. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.11.014 · Cited by 95
“Chronic inflammation contributes to insulin resistance and metabolic diseases [20,38–40].”
BackgroundG Protein–Coupled Receptor Kinase 2 Plays a Relevant Role in Insulin Resistance and Obesity
García‐Guerra, L., Nieto-Vázquez, I., Vila‐Bedmar, R., Jurado-Pueyo, M., Zalba, G., Dı́ez, J., Murga, C., Fernández‐Veledo, S., Mayor, F., & Lorenzo, M. (2010) · Diabetes · doi:10.2337/db10-0771 · Cited by 92
“Alterations in any of the key components of the insulinsignaling cascade, including negative regulators, have been proposed to contribute to insulin resistance (1,2).”
BackgroundRetractedLü, J., Zeng, Y., Hou, W.-R., Zhang, S., Li, L., Luo, X., Xi, W., Chen, Z., & Xiang, M. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.09.007 · Cited by 93
“IR and IRS1 are two vital molecules involved in this insulin signaling pathway linking peripheral insulin action: IR recruits and phosphorylates cellular substrates to initiate signal transduction [27], while IRS1 controls insulin action by binding with upstream common proteins [28].”
BackgroundPajvani, U. B., & Accili, D. (2015) · Diabetologia · doi:10.1007/s00125-015-3722-5 · Cited by 92
“The biochemistry of insulin action focused on signalling to the glucose transporter GLUT4 [11], and the pathophysiology of insulin resistance emphasised the impairment of the insulindependent transport and utilisation of glucose in muscle [12], and the role of glucose transporters in that process [13].”
Shpakov, A. O., Derkach, K. V., & Berstein, L. M. (2015) · Future Science OA · doi:10.4155/fso.15.23 · Cited by 93
The mTOR Signaling Pathway in the Brain: Focus on Epilepsy and Epileptogenesis
Russo, E., Citraro, R., Constanti, A., & Sarro, G. D. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8314-5 · Cited by 91
Choi, E., Kikuchi, S., Gao, H., Brodzik, K., Nassour, I., Yopp, A., Singal, A. G., Zhu, H., & Yu, H. (2019) · Nature Communications · doi:10.1038/s41467-019-09318-3 · Cited by 89
Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease
Velázquez, R., Tran, A., Ishimwe, E., Denner, L. A., Dave, N., Oddo, S., & Dineley, K. T. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.06.003 · Cited by 89
“…of the PDK1/AKT pathways, induces glycogen synthesis through the target of rapamycin complexes to control AMP-activated protein kinase (AMPK), energy metabolism, mitochondrial function, synaptic plasticity and memory (Cheng et al., 2010; Kleinridders et al., 2014; Stoica et al., 2011; White, 2003).”
BackgroundMitochondrial function in ageing: coordination with signalling and transcriptional pathways
Yin, F., Sancheti, H., Liu, Z., & Cadenas, E. (2015) · The Journal of Physiology · doi:10.1113/jp270541 · Cited by 93
“This dysregulation leads to obesity, type 2 diabetes, cardiovascular disease, and neurodegeneration (Saltiel & Kahn, 2001; White, 2003; Cheng et al. 2010).”
BackgroundNieto-Vázquez, I., Fernández‐Veledo, S., de Álvaro, C., Rondinone, C. M., Valverde, Á. M., & Lorenzo, M. (2007) · Diabetes · doi:10.2337/db06-0989 · Cited by 92
“The mechanisms proposed could involve proteasome-mediated degradation, phosphatasemediated dephosphorylation, and serine phosphorylation of IRS-1, converting IRS-1 in an inhibitor of the insulin receptor tyrosine kinase activity, as reviewed previously (11,12).”
MethodRetractedArcidiacono, B., CHIEFARI, E. D., Foryst‐Ludwig, A., Currò, G., Navarra, G., Brunetti, F. S., Mirabelli, M., Corigliano, D. M., Kintscher, U., Britti, D., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102912 · Cited by 95
Relationship Between Visceral Adiposity and Bone Mineral Density in Korean Adults
Choi, H. S., Kim, K. J., Kim, K. M., Hur, N. W., Rhee, Y., Han, D. S., Lee, E. J., & Lim, S.-K. (2010) · Calcified Tissue International · doi:10.1007/s00223-010-9398-4 · Cited by 92
“In addition, visceral adipose tissue secretes various factors that inhibit insulin signaling such as free fatty acids, TNF-a, and resistin, thereby causing insulin resistance [50–52].”
BackgroundMultifactorial Basis and Therapeutic Strategies in Metabolism-Related Diseases
Guerra, J. V. D. S., Dias, M. M. G., Brilhante, A. J. V. C., Terra, M. F., García‐Arévalo, M., & Figueira, A. C. M. (2021) · Nutrients · doi:10.3390/nu13082830 · Cited by 92
Deregulation of brain insulin signaling in Alzheimer’s disease
Chen, Y., Deng, Y., Zhang, B., & Gong, C. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1408-x · Cited by 82
“The phosphorylated/activated IR then recruits insulin receptor substrate (IRS) protein to the plasma membrane([15]) and phosphorylates it([16]), which in turn promotes the recruitment and activation of phosphatidylinositol-3 kinase (PI3K) and growth factor receptor-bound protein 2.”
BackgroundThe Role of Ca2+ Influx for Insulin-Mediated Glucose Uptake in Skeletal Muscle
Lanner, J. T., Katz, A., Tavi, P., Sandström, M., Zhang, S., Wretman, C., James, S. R., Fauconnier, J., Lännergren, J., Bruton, J. D., et al. (2006) · Diabetes · doi:10.2337/db05-1613 · Cited by 83
“5 mol/l), which inhibits phosphoinositide 3-kinase; this phosphorylation is an early step in the insulin signaling cascade (4).”
BackgroundFauconnier, J., Lanner, J. T., Zhang, S., Tavi, P., Bruton, J. D., Katz, A., & Westerblad, H. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2375 · Cited by 84
“5 mol/l) completely blocked the effects of insulin on Ca(2) transients in both wild-type and ob/ob cells (Table 1), which suggests that the effects of insulin occurred via the PI3K-dependent signaling pathway (10,11).”
BackgroundDenver, P., & McClean, P. L. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.238608 · Cited by 89
“Activation of the insulin receptor (IR) is followed by recruitment of insulin receptor substrate (IRS) proteins intracellularly, usually IRS-1 or IRS-2 (White, 2003; Boura-Halfon and Zick, 2009).”
BackgroundSlattery, M. L., & Fitzpatrick, F. A. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0191 · Cited by 82
Vinayagam, A., Kulkarni, M. M., Sopko, R., Sun, X., Hu, Y., Nand, A., Villalta, C., Moghimi, A. M., Yang, X., Mohr, S. E., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.029 · Cited by 81
“…is reflected by the fact that dysregulated signaling can lead to a range of systemic disorders including diabetes, obesity, inflammation, cancer, hypertension, high levels of cholesterol and other lipids, heart disease, kidney disease, female infertility and neurodegeneration (White, 2003).”
BackgroundBuitrago, C., Arango, N. S., & Boland, R. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23444 · Cited by 79
“On the other hand, related to the skeletal muscle differentiation process, PI3K/Akt signaling modulates muscle gene expression during myogenic differentiation [White, 2003].”
BackgroundOrmazabal, P., Scazzocchio, B., Varı́, R., Santangelo, C., D’Archivio, M., Silecchia, G., Iacovelli, A., Giovannini, C., & Masella, R. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0075-4 · Cited by 77
Chandhini, S., Trumboo, B., Jose, S., Varghese, T., Rajesh, M., & Rejish Kumar, V. J. (2021) · Fish Physiology and Biochemistry · doi:10.1007/s10695-021-00961-6 · Cited by 77
“2001) and Raf-MekErk1/2 cascade (White 2003).”
Insulin Receptor Substrate 2 Is Essential for Maturation and Survival of Photoreceptor Cells
Yi, X., Schubert, M., Peachey, N. S., Suzuma, K., Burks, D. J., Kushner, J. A., Suzuma, I., Cahill, C., Flint, C. L., Dow, M. A., et al. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3664-04.2005 · Cited by 77
“The receptors for insulin and IGF1 are tyrosine kinases that recruit and phosphorylate various proteins to generate physiological responses (White, 2003).”
CDK4 is an essential insulin effector in adipocytes
Lagarrigue, S., López‐Mejía, I. C., Denechaud, P., Escoté, X., Castillo‐Armengol, J., Jiménez, V., Chavey, C., Giralt, A., Lai, Q., Zhang, L., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81480 · Cited by 76
“Defects in insulin signaling contribute to insulin resistance, a common complication of obesity that occurs early in the pathogenesis of type 2 diabetes and cardiovascular disease (2, 3).”
BackgroundRetractedMehdi, M. Z., Pandey, N. R., Pandey, S., & Srivastava, A. K. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.1014 · Cited by 75
Insulin resistance and hepatitis C: an evolving story
Eslam, M., Khattab, M. A., & Harrison, S. A. (2011) · Gut · doi:10.1136/gut.2010.228262 · Cited by 74
“Unlike other receptor tyrosine kinases, most functions of the insulin receptor require accessory molecules known as insulin receptor substrates (IRSs) (1e4) to engage multiple downstream signalling pathways.(4) 5 Insulin binding results in autophosphorylation of the receptor and tyrosine phosphorylation of intracellul…”
BackgroundChen, S., Li, X., Liu, L., Liu, C., & Han, X. (2017) · The FASEB Journal · doi:10.1096/fj.201700741rr · Cited by 75
“Proinflammatory cytokines, particularly TNF-a, promote the serine phosphorylation of insulin receptor substrate 1, a critical step to induce insulin resistance (52).”
BackgroundInositol - An effective growth promotor?
Lee, S. A., & Bedford, M. R. (2016) · World s Poultry Science Journal · doi:10.1017/s0043933916000660 · Cited by 80
“Stimulation of the IP3K signalling pathway generates PtdIns(3,4,5)P3, leading to the activation of the Akt (protein kinase B) cascade, which regulates cellular functions such as cell survival and metabolism (White, 2003).”
Backgroundβ‐cell mass in people with type 2 diabetes
Cho, J., Kim, J., Shin, J., Shin, J., & Yoon, K. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00072.x · Cited by 69
Identification of the tyrosine phosphatase PTP-MEG2 as an antagonist of hepatic insulin signaling
Cho, C. Y., Koo, S., Wang, Y., Callaway, S., Hedrick, S. A., Mak, P. A., Orth, A. P., Peters, E. C., Sáez, E., Montminy, M., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.03.006 · Cited by 73
“Binding of insulin to its cognate receptor stimulates receptor tyrosine kinase activity, resulting in the phosphorylation of several substrates, including insulin receptor substrate (IRS) proteins (White, 2003).”
The role of insulin receptor signaling in zebrafish embryogenesis
Toyoshima, Y., Monson, C., Duan, C., Wu, Y., Gao, C., Yakar, S., Sadler, K. C., & LeRoith, D. (2008) · Endocrinology · doi:10.1210/en.2008-0329 · Cited by 72
Lourenco, M. V., Ferreira, S. T., & Felice, F. G. D. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.03.003 · Cited by 74
Haskell‐Luevano, C., Schaub, J. W., Andreasen, A., Haskell, K. R., Moore, M. C., Koerper, L. M., Rouzaud, F., Baker, H. V., Millard, W. J., Walter, G., et al. (2009) · The FASEB Journal · doi:10.1096/fj.08-109686 · Cited by 72
“The leptin and insulin hormones signal in the hypothalamic neurons through the phosphatidylinositol 3-kinase pathway that is inhibited by phosphatase with tensin homology (Pten) (49, 50).”
BackgroundCNS-targets in control of energy and glucose homeostasis
Kleinridders, A., Könner, A. C., & Brüning, J. C. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.10.006 · Cited by 74
Dual role of the coactivator TORC2 in modulating hepatic glucose output and insulin signaling
Canettieri, G., Koo, S., Berdeaux, R., Heredia, J., Hedrick, S. A., Zhang, X., & Montminy, M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.008 · Cited by 71
“Hepatic IRS2 expression is often reduced in mouse models of Type II diabetes, reflecting in part the inhibitory effects of hyperinsulinemia on expression of the IRS2 gene (Brady, 2004; White, 2003).”
BackgroundRen, L., Zhou, X., Huang, X., Wang, C., & Li, Y. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.12.015 · Cited by 71
The brown adipose cell: a model for understanding the molecular mechanisms of insulin resistance
Valverde, Á. M., Benito, M., & Lorenzo, M. (2005) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.2004.01384.x · Cited by 70
Insulin Signal Mimicry as a Mechanism for the Insulin-Like Effects of Vanadium
Mehdi, M. Z., Pandey, S., Théberge, J.-F., & Srivastava, A. K. (2006) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:44:1:073 · Cited by 71
“Once activated, IR-PTK can phosphorylate several cytosolic insulin receptor substrates (IRSs and Shc), which serve as docking sites for Src homology (SH)-2 domain-containing signaling molecules (23), triggering the activation of two key signaling pathways (Fig.”
BackgroundLi, D., Yin, X. H., Zmuda, E. J., Wolford, C. C., Dong, X. C., White, M. F., & Hai, T. (2007) · Diabetes · doi:10.2337/db07-0717 · Cited by 67
“Although the IRS family of proteins includes IRS1–IRS6 and other proteins such as GAB1, GAB2, and CBL (2,3), the majority of the insulin action appears to be mediated by IRS1 and IRS2 (rev.”
BackgroundCellular inflammatory responses: Novel insights for obesity and insulin resistance
Chen, H. (2006) · Pharmacological Research · doi:10.1016/j.phrs.2006.03.003 · Cited by 68
Insulin signaling and life span
Avogaro, A., de Kreutzenberg, S. V., & Fadini, G. P. (2009) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-009-0721-8 · Cited by 66
“Most, if not all, insulin signals are produced or modulated through tyrosine phosphorylation of IRS1 or its homolog IRS2 or other scaffold proteins [ 136 ].”
Background(2008) · doi:10.1016/j.cmet.2008.06.010 · Cited by 67
“…of insulin (and IGF) receptors by (1) providing a juxtamembrane localiza- tion signal for PIP3 generation, (2) amplify- Cell Me ing the signal engendered by receptor autophosphorylation, and (3) engaging a panoply of substrates that account for the diverse actions of insulin (White, 2003).”
BackgroundSrinivasan, M., Mitrani, P., Sadhanandan, G., Dodds, C., Shbeir‐ElDika, S., Thamotharan, S., Ghanim, H., Dandona, P., Devaskar, S. U., & Patel, M. S. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0021 · Cited by 66
“Hormone binding to the IR results in rapid autophosphorylation of the receptor followed by tyrosine phosphorylation of IR substrate proteins, inducing an activation of the downstream pathways such as the MAPK and PI3K cascades (White 2003).”
BackgroundMolecular Profiling of Pancreatic Neuroendocrine Tumors in Sporadic and Von Hippel-Lindau Patients
Speisky, D., Ducès, A., Bièche, I., Rebours, V., Hammel, P. R., Sauvanet, A., Richard, S., Bédossa, P., Vidaud, M., Murat, A., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2759 · Cited by 68
Effects of insulin on the skin: possible healing benefits for diabetic foot ulcers
Emanuelli, T., Burgeiro, A., & Carvalho, E. (2016) · Archives of Dermatological Research · doi:10.1007/s00403-016-1686-z · Cited by 67
“Besides regulating glucose and lipid metabolism, insulin is involved in processes including protein synthesis, mitochondrial biogenesis, growth, autophagy, proliferation, differentiation, and migration [153].”
BackgroundAmino Acid Sensing via General Control Nonderepressible-2 Kinase and Immunological Programming
Battu, S., Minhas, G., Mishra, A., & Khan, N. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01719 · Cited by 69
“mTOR being a central regulator of amino acid and insulin signaling (97, 98), under amino acid abundance, it phosphorylates IRS1 (at serine 307) and inhibits the downstream insulin signaling (99, 100).”
BackgroundSynergistic activation of the insulin receptor via two distinct sites
Li, J., Park, J., Mayer, J. P., Webb, K. J., Uchikawa, E., Wu, J., Liu, S., Zhang, X., Stowell, M. H. B., Choi, E., et al. (2022) · Nature Structural & Molecular Biology · doi:10.1038/s41594-022-00750-6 · Cited by 65
Potential health concerns of dietary phosphorus: cancer, obesity, and hypertension
Anderson, J. J. B. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12208 · Cited by 66
Energy balance, insulin‐related genes and risk of colon and rectal cancer
Slattery, M. L., Murtaugh, M. A., Caan, B. J., Ma, K.-N., Neuhausen, S. L., & Samowitz, W. S. (2005) · International Journal of Cancer · doi:10.1002/ijc.20843 · Cited by 62
Therapeutic neovascularization for coronary disease: current state and future prospects
Lassaletta, A. D., Chu, L. M., & Sellke, F. W. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0200-1 · Cited by 64
“Like VEGF, insulin has a tyrosine kinase receptor and shares many downstream components with the VEGF angiogenic pathway [17, 27, 93, 106].”
BackgroundSadagurski, M., Leshan, R. L., Patterson, C. M., Rozzo, A., Kuznetsova, A., Skorupski, J. C., Jones, J. C., DePinho, R. A., Myers, M. G., & White, M. F. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.011 · Cited by 66
Yi, Z., Langlais, P. R., Filippis, E. A. D., Luo, M., Flynn, C. R., Schroeder, S., Weintraub, S. T., Mapes, R., & Mandarino, L. J. (2007) · Diabetes · doi:10.2337/db06-1355 · Cited by 65
“3 Introduction Through the efforts of a large number of investigators, many of the details of insulin signaling have been defined on a molecular level (1).”
BackgroundInsulin-signaling Pathway Regulates the Degradation of Amyloid β-protein via Astrocytes
Yamamoto, N., Ishikuro, R., Tanida, M., Suzuki, K., Ikeda‐Matsuo, Y., & Sobue, K. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.06.018 · Cited by 65
Fox, A. S., Oler, J. A., Shelton, S. E., Nanda, S. A., Davidson, R. J., Roseboom, P. H., & Kalin, N. H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206723109 · Cited by 57
“In the periphery, IRS2 regulates insulin sensitivity and in the brain IRS2 impacts multiple functions including reward (58), memory (59, 60), and energy homeostasis (61, 62).”
BackgroundHuang, S., Kaw, M., Harris, M., Ebraheim, N. A., McInerney, M. F., Najjar, S. M., & Lecka‐Czernik, B. (2010) · Bone · doi:10.1016/j.bone.2009.12.020 · Cited by 63
“Insulin action on bone may involve direct signaling through the insulin receptor, activation of bone anabolic IGF-1 signaling by binding to IGF-1 receptor, or synergistic effects with other anabolic agents such as parathyroid hormone (PTH) [21,24].”
Lanner, J. T., Bruton, J. D., Assefaw‐Redda, Y., Andronache, Z., Zhang, S., Severa, D., Zhang, Z., Melzer, W., Zhang, S., Katz, A., et al. (2009) · The FASEB Journal · doi:10.1096/fj.08-116814 · Cited by 62
Guo, S., Dunn, S. L., & White, M. F. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0092 · Cited by 64
“Type 2 diabetes emerges when nutrient homeostasis is dysregulated by peripheral insulin resistance and pancreatic -cell failure (1, 39).”
BackgroundPark, S. Y., Choi, G. H., Choi, H. I., Ryu, J., Jung, C. Y., & Lee, W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409399200 · Cited by 61
Insulin mediated novel therapies for the treatment of Alzheimer's disease
Dubey, S. K., Lakshmi, K. K., Krishna, K. V., Agrawal, M., Singhvi, G., Saha, R. N., Saraf, S., Saraf, S., Shukla, R., & Alexander, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117540 · Cited by 62
Type 2 Diabetes (T2DM) and Parkinson’s Disease (PD): a Mechanistic Approach
Sabari, S. S., Balasubramani, K., Iyer, M., Babu, H. W. S., Venkatesan, D., Gopalakrishnan, A. V., Narayanaswamy, A., Kumar, N. S., & Vellingiri, B. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03359-y · Cited by 64
“Therefore, understanding the role of insulin and its signalling pathway is essential to investigate, in T2DM and PD [20].”
BackgroundTao, R., Xiong, X., Harris, R. A., White, M. F., & Dong, X. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071997 · Cited by 60
“Insulin receptor substrates (Irs) play an essential role in the insulin signal transduction through a direct mediation of insulin receptor activities [19].”
BackgroundZhu, H., Chen, B., Cheng, Y., Zhou, Y. X., Yan, Y., Luo, Q., Jiang, Y., Sheng, J., Ding, G., & Huang, H. (2019) · Diabetes · doi:10.2337/db18-1151 · Cited by 63
“Defective insulin secretion and action are twomajor results of diabetes (49,50).”
BackgroundIRS‐2 branch of IGF‐1 receptor signaling is essential for appropriate timing of myelination
Freude, S., Leeser, U., Müller, M., Hettich, M. M., Udelhoven, M., Schilbach, K., Tobe, K., Kadowaki, T., Köhler, C. N., Schröder, H., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05631.x · Cited by 59
Masharani, U. B., Maddux, B. A., Li, X., Sakkas, G. K., Mulligan, K. M., Schambelan, M., Goldfine, I. D., & YOUNGREN, J. F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019878 · Cited by 62
“[8,9].”
Involvement of insulin receptor substrates in cognitive impairment and Alzheimer’s disease
Taguchi, A., Tanokashira, D., & Fukuokaya, W. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.253535 · Cited by 57
“…the biological effects of insulin/IGF1 signaling (IIS) on glucose or lipid metabolism are mediated via insulin receptor substrate (IRS)1 and IRS2 (White, 2003) whereas the tyrosine kinase activation of IR/IGF1R stimulates the phosphorylation of other scaffold proteins such as SH2B, GABs, DOCKs,…”
Nutritional approaches for managing obesity-associated metabolic diseases
Botchlett, R. E., Woo, S., Liu, M., Pei, Y., Guo, X., Li, H., & Wu, C. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0580 · Cited by 65
“Inflammation/proinflammatory cytokines are widely known to interfere with the insulin signaling pathway, including suppression/interference of IRS-1 and IRS-2 (White 2003).”
BackgroundTherapeutic Mechanisms of Herbal Medicines Against Insulin Resistance: A Review
Li, J., Bai, L., Wei, F., Zhao, J., Wang, D., Xiao, Y., Yan, W., & Wei, J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00661 · Cited by 61
“Insulin activates the PI3K/Akt pathway, which is responsible for glucose uptake, and the MAPK pathway, which is critical for IR (Saltiel and Kahn, 2001).”
BackgroundInfluential
Metadata
- Authors
- White, M. F.
- Affiliations
- Joslin Diabetes Center (US)
- Corresponding author
- White, Morris F.
- ORCID
- White, Morris F.
- Venue
- Science
- Published
- 2003-12-05
- Volume
- 302
- Issue
- 5651
- Pages
- 1710-1711
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2115177689
- Cited by
- 733
- References
- 19
- Citations by year
- 2026: 7 · 2025: 17 · 2024: 13 · 2023: 21 · 2022: 24 · 2021: 35 · 2020: 32 · 2019: 30 · 2018: 36 · 2017: 35 · 2016: 39 · 2015: 47 · 2014: 35 · 2013: 39 · 2012: 50
- FWCI
- 9.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- insulin signaling, insulin resistance, obesity, type 2 diabetes, pancreatic beta-cell failure, chronic inflammation, insulin receptor substrate 2
- MeSH terms
- Animals, Diabetes Mellitus, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Humans, Inflammation, Insulin, Insulin Resistance, Islets of Langerhans, Models, Biological, Obesity, Phosphoproteins, Phosphorylation, Receptor, Insulin, Somatomedins, Signal Transduction, Cytokines, Intracellular Signaling Peptides and Proteins, Mice, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review